(Q39138906)

9 September 2017

title

Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling (English)

1 reference

9 September 2017

1 reference

0 references

1

1 reference

9 September 2017

Pierre-Olivier Couraud

9

object named as

Pierre-Olivier Couraud

1 reference

9 September 2017

Iris C Salaroglio

2

1 reference

9 September 2017

Martha L Pinzòn-Daza

3

1 reference

9 September 2017

Valentina Caldera

4

1 reference

9 September 2017

Ivana Campia

5

1 reference

9 September 2017

Joanna Kopecka

6

1 reference

9 September 2017

Marta Mellai

7

1 reference

9 September 2017

Laura Annovazzi

8

1 reference

9 September 2017

Amalia Bosia

10

1 reference

9 September 2017

Dario Ghigo

11

1 reference

9 September 2017

Davide Schiffer

12

1 reference

9 September 2017

publication date

15 June 2013

1 reference

Cellular and Molecular Life Sciences

9 September 2017

published in

1 reference

9 September 2017

volume

71

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

499-516

1 reference

Molecular targeting of glioblastoma: Drug discovery and therapies

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

New (alternative) temozolomide regimens for the treatment of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Occipitoatlantal dislocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Differentiation of the brain vasculature: the answer came blowing by the Wnt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Molecular sieving characteristics of the cultured endothelial monolayer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Digoxin and ouabain increase the synthesis of cholesterol in human liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Cell-type-specific regulation of raft-associated Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Wnt/beta-catenin signaling controls development of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Wnt4 activates the canonical β-catenin pathway and regulates negatively myostatin: functional implication in myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1397-Y

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

21 January 2018

1 reference

12 December 2020

Metabolic activation of temozolomide measured in vivo using positron emission tomography

1 reference

12 December 2020

Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells

1 reference

12 December 2020

Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study

1 reference

12 December 2020

Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells.

1 reference

12 December 2020

Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling

1 reference

12 December 2020

A novel camptothecin analog with enhanced antitumor activity.

1 reference

12 December 2020

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

1 reference

12 December 2020

10.1007/S00018-013-1397-Y

Identifiers

DOI

1 reference

9 September 2017

1 reference